CryoCath Technologies Inc. (CCT) develops, manufactures and markets cryoablation catheter systems for the treatment of cardiac arrhythmias, tumours and other obstructions in the body. These systems comprise flexible, steerable catheters that are supported by sophisticated electromechanical consoles that deliver and recover refrigerants from the catheters that are placed in the body through minimally-invasive means. Advanced software controls are incorporated into the console in order to monitor and control catheter performance.